{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T23:49:56Z","timestamp":1772063396535,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T00:00:00Z","timestamp":1479859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T00:00:00Z","timestamp":1479859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Distant metastasis is the primary failure pattern of nasopharyngeal carcinoma(NPC) in intensity-modulated radiation therapy(IMRT) era. This study was conducted to find the impact of genetic variations in the phosphatidylinositol 3-kinase(PI3K)\/phosphatase and tensin homologue(PTEN)\/v-akt murine thymoma viral oncogene homologue(AKT)\/mammalian target of rapamycin(mTOR) pathway on the risk of distant metastasis in NPC. We genotyped 16 single-nucleotide polymorphisms(SNPs) in five core genes in this pathway from 496 patients treated by IMRT with or without chemotherapy. The relationships between genetic polymorphisms and distant progression were evaluated. We observed that two loci in the AKT1 gene(rs3803300 and rs2494738 alone or combined) were associated with prognosis, with patients carrying at least one variant allele had significantly reduced risk of distant failure, especially in N2-3 group. In addition, we found that genetic variation may had some joint effect with N classification in recursive-partitioning analysis(RPA) analysis, with which patients were stratified into four different risk subgroups (RPA model): RPA1(low risk), RPA2(moderate risk), RPA3(high risk) and RPA4(highest risk). Our findings suggested that genetic variations within the PI3K signaling pathway modulate the development and invasion of NPC patients. Further research is needed to replicate the study in other centers and races, and to unravel the functional significance of these polymorphisms.<\/jats:p>","DOI":"10.1038\/srep37576","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T10:32:37Z","timestamp":1479897157000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Genetic variations in the PI3K-PTEN-AKT-mTOR pathway are associated with distant metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy"],"prefix":"10.1038","volume":"6","author":[{"given":"Qiaojuan","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianzhu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaojun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianji","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianglin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,23]]},"reference":[{"key":"BFsrep37576_CR1","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/S0140-6736(05)66698-6","volume":"365","author":"WI Wei","year":"2005","unstructured":"Wei, W. I. & Sham, J. S. Nasopharyngeal carcinoma. Lancet 365, 2041\u20132054 (2005).","journal-title":"Lancet"},{"key":"BFsrep37576_CR2","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1200\/JCO.2015.60.9347","volume":"33","author":"AW Lee","year":"2015","unstructured":"Lee, A. W., Ma, B. B., Ng, W. T. & Chan, A. T. Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective. J Clin Oncol 33, 3356\u20133364 (2015).","journal-title":"J Clin Oncol"},{"key":"BFsrep37576_CR3","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrc2664","volume":"9","author":"JA Engelman","year":"2009","unstructured":"Engelman, J. A. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 9, 550\u2013562 (2009).","journal-title":"Nat Rev Cancer"},{"key":"BFsrep37576_CR4","doi-asserted-by":"publisher","first-page":"154","DOI":"10.5501\/wjv.v1.i6.154","volume":"1","author":"J Chen","year":"2012","unstructured":"Chen, J. Roles of the PI3K\/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications. World J Virol 1, 154\u2013161 (2012).","journal-title":"World J Virol"},{"key":"BFsrep37576_CR5","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/hed.23604","volume":"37","author":"K Pfisterer","year":"2015","unstructured":"Pfisterer, K. et al. PI3K\/PTEN\/AKT\/mTOR polymorphisms: association with clinical outcome in patients with head and neck squamous cell carcinoma receiving cetuximab-docetaxel. Head Neck 37, 471\u2013478 (2015).","journal-title":"Head Neck"},{"key":"BFsrep37576_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.lfs.2015.11.011","volume":"143","author":"L Guo","year":"2015","unstructured":"Guo, L. et al. Genetic variations in the PI3K\/AKT pathway predict platinum-based neoadjuvant chemotherapeutic sensitivity in squamous cervical cancer. Life Sci 143, 217\u2013224 (2015).","journal-title":"Life Sci"},{"key":"BFsrep37576_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/cam4.564","volume":"5","author":"Y Tang","year":"2016","unstructured":"Tang, Y. et al. Genetic variants in PI3K\/AKT pathway are associated with severe radiation pneumonitis in lung cancer patients treated with radiation therapy. Cancer Med 5, 24\u201332 (2016).","journal-title":"Cancer Med"},{"key":"BFsrep37576_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/jop.12211","volume":"44","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. Genetic variants in AKT1 gene were associated with risk and survival of OSCC in Chinese Han Population. J Oral Pathol Med 44, 45\u201350 (2015).","journal-title":"J Oral Pathol Med"},{"key":"BFsrep37576_CR9","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s00432-014-1663-x","volume":"140","author":"X Wang","year":"2014","unstructured":"Wang, X. et al. A GG allele of 3\u2032-side AKT1 SNP is associated with decreased AKT1 activation and better prognosis of gastric cancer. J Cancer Res Clin Oncol 140, 1399\u20131411 (2014).","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFsrep37576_CR10","doi-asserted-by":"publisher","first-page":"6252","DOI":"10.1158\/1078-0432.CCR-13-1093","volume":"19","author":"Q Li","year":"2013","unstructured":"Li, Q. et al. Associations between single-nucleotide polymorphisms in the PI3K-PTEN-AKT-mTOR pathway and increased risk of brain metastasis in patients with non-small cell lung cancer. Clin Cancer Res 19, 6252\u20136260 (2013).","journal-title":"Clin Cancer Res"},{"key":"BFsrep37576_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.lungcan.2010.04.008","volume":"71","author":"X Pu","year":"2011","unstructured":"Pu, X. et al. PI3K\/PTEN\/AKT\/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy. Lung Cancer 71, 82\u201388 (2011).","journal-title":"Lung Cancer"},{"key":"BFsrep37576_CR12","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1093\/carcin\/bgq110","volume":"31","author":"M Chen","year":"2010","unstructured":"Chen, M. et al. Genetic variations of the PI3K-AKT-mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patients. Carcinogenesis 31, 1387\u20131391 (2010).","journal-title":"Carcinogenesis"},{"key":"BFsrep37576_CR13","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1200\/JCO.2008.17.6297","volume":"27","author":"MA Hildebrandt","year":"2009","unstructured":"Hildebrandt, M. A. et al. Genetic variations in the PI3K\/PTEN\/AKT\/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy. J Clin Oncol 27, 857\u2013871 (2009).","journal-title":"J Clin Oncol"},{"key":"BFsrep37576_CR14","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1158\/1078-0432.CCR-11-3271","volume":"18","author":"MA Hildebrandt","year":"2012","unstructured":"Hildebrandt, M. A. et al. Genetic variants in the PI3K\/PTEN\/AKT\/mTOR pathway predict head and neck cancer patient second primary tumor\/recurrence risk and response to retinoid chemoprevention. Clin Cancer Res 18, 3705\u20133713 (2012).","journal-title":"Clin Cancer Res"},{"key":"BFsrep37576_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/jso.22071","volume":"105","author":"MJ Kim","year":"2012","unstructured":"Kim, M. J. et al. AKT1 polymorphisms and survival of early stage non-small cell lung cancer. J Surg Oncol 105, 167\u2013174 (2012).","journal-title":"J Surg Oncol"},{"key":"BFsrep37576_CR16","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.7314\/APJCP.2012.13.5.2157","volume":"13","author":"JL Xu","year":"2012","unstructured":"Xu, J. L. et al. Genetic variants in the PI3K\/PTEN\/AKT\/mTOR pathway predict platinum-based chemotherapy response of advanced non-small cell lung cancers in a Chinese population. Asian Pac J Cancer Prev 13, 2157\u20132162 (2012).","journal-title":"Asian Pac J Cancer Prev"},{"key":"BFsrep37576_CR17","first-page":"13314","volume":"8","author":"L Lin","year":"2015","unstructured":"Lin, L., Zhang, Z., Zhang, W., Wang, L. & Wang, J. Roles of genetic variants in the PI3K\/PTEN pathways in susceptibility to colorectal carcinoma and clinical outcomes treated with FOLFOX regimen. Int J Clin Exp Pathol 8, 13314\u201313322 (2015).","journal-title":"Int J Clin Exp Pathol"},{"key":"BFsrep37576_CR18","doi-asserted-by":"publisher","first-page":"5251","DOI":"10.1158\/0008-5472.CAN-04-0538","volume":"64","author":"JA Morrison","year":"2004","unstructured":"Morrison, J. A., Gulley, M. L., Pathmanathan, R. & Raab-Traub, N. Differential signaling pathways are activated in the Epstein-Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma. Cancer Res 64, 5251\u20135260 (2004).","journal-title":"Cancer Res"},{"key":"BFsrep37576_CR19","doi-asserted-by":"publisher","first-page":"6997","DOI":"10.1158\/0008-5472.CAN-08-1178","volume":"68","author":"KH Shair","year":"2008","unstructured":"Shair, K. H., Schnegg, C. I. & Raab-Traub, N. EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration. Cancer Res 68, 6997\u20137005 (2008).","journal-title":"Cancer Res"},{"key":"BFsrep37576_CR20","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1038\/onc.2014.341","volume":"34","author":"LM Cai","year":"2015","unstructured":"Cai, L. M. et al. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN. Oncogene 34, 2156\u20132166 (2015).","journal-title":"Oncogene"},{"key":"BFsrep37576_CR21","doi-asserted-by":"publisher","first-page":"7353","DOI":"10.1038\/ncomms8353","volume":"6","author":"L Cai","year":"2015","unstructured":"Cai, L. et al. Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma. Nat Commun 6, 7353 (2015).","journal-title":"Nat Commun"},{"key":"BFsrep37576_CR22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3892\/or.2014.3220","volume":"32","author":"H Jiang","year":"2014","unstructured":"Jiang, H. et al. Blocking PI3K\/Akt signaling attenuates metastasis of nasopharyngeal carcinoma cells through induction of mesenchymal-epithelial reverting transition. Oncol Rep 32, 559\u2013566 (2014).","journal-title":"Oncol Rep"},{"key":"BFsrep37576_CR23","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.ijrobp.2008.12.015","volume":"75","author":"S Lin","year":"2009","unstructured":"Lin, S. et al. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys 75, 1071\u20131078 (2009).","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFsrep37576_CR24","doi-asserted-by":"crossref","unstructured":"A haplotype map of the human genome. Nature 437, 1299\u20131320 (2005).","DOI":"10.1038\/nature04226"},{"key":"BFsrep37576_CR25","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","volume":"19","author":"A H","year":"1974","unstructured":"H, A. A new look at the statistical model identification. IEEE Trans Automat Contr 19, 716\u2013723 (1974).","journal-title":"IEEE Trans Automat Contr"},{"key":"BFsrep37576_CR26","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1001\/jama.1982.03320430047030","volume":"247","author":"FE Harrell Jr.","year":"1982","unstructured":"Harrell, F. E., Jr., Califf, R. M., Pryor, D. B., Lee, K. L. & Rosati, R. A. Evaluating the yield of medical tests. Jama 247, 2543\u20132546 (1982).","journal-title":"Jama"},{"key":"BFsrep37576_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2004.02.009","volume":"208","author":"A Loktionov","year":"2004","unstructured":"Loktionov, A. Common gene polymorphisms, cancer progression and prognosis. Cancer Lett 208, 1\u201333 (2004).","journal-title":"Cancer Lett"},{"key":"BFsrep37576_CR28","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/21224","volume":"399","author":"S Dimmeler","year":"1999","unstructured":"Dimmeler, S. et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399, 601\u2013605 (1999).","journal-title":"Nature"},{"key":"BFsrep37576_CR29","first-page":"2172","volume":"63","author":"SJ Grille","year":"2003","unstructured":"Grille, S. J. et al. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 63, 2172\u20132178 (2003).","journal-title":"Cancer Res"},{"key":"BFsrep37576_CR30","doi-asserted-by":"publisher","first-page":"16297","DOI":"10.1073\/pnas.0508390102","volume":"102","author":"SL Harris","year":"2005","unstructured":"Harris, S. L. et al. Detection of functional single-nucleotide polymorphisms that affect apoptosis. Proc Natl Acad Sci USA 102, 16297\u201316302 (2005).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep37576_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/ng1296","volume":"36","author":"ES Emamian","year":"2004","unstructured":"Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M. & Gogos, J. A. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 36, 131\u2013137 (2004).","journal-title":"Nat Genet"},{"key":"BFsrep37576_CR32","doi-asserted-by":"publisher","first-page":"e0140216","DOI":"10.1371\/journal.pone.0140216","volume":"10","author":"SY Lee","year":"2015","unstructured":"Lee, S. Y. et al. A Panel of Genetic Polymorphism for the Prediction of Prognosis in Patients with Early Stage Non-Small Cell Lung Cancer after Surgical Resection. PLoS One 10, e0140216 (2015).","journal-title":"PLoS One"},{"key":"BFsrep37576_CR33","first-page":"100","volume":"5","author":"ML Slattery","year":"2014","unstructured":"Slattery, M. L., Lundgreen, A., Mullany, L. E., Penney, R. B. & Wolff, R. K. Influence of CHIEF pathway genes on gene expression: a pathway approach to functionality. Int J Mol Epidemiol Genet 5, 100\u2013111 (2014).","journal-title":"Int J Mol Epidemiol Genet"},{"key":"BFsrep37576_CR34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0960-9822(06)00122-9","volume":"7","author":"DR Alessi","year":"1997","unstructured":"Alessi, D. R. et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol 7, 261\u2013269 (1997).","journal-title":"Curr Biol"},{"key":"BFsrep37576_CR35","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s13277-015-3893-1","volume":"37","author":"X Zhang","year":"2016","unstructured":"Zhang, X. et al. Polymorphisms in epidermal growth factor receptor (EGFR) and AKT1 as possible predictors of clinical outcome in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors. Tumour Biol 37, 1061\u20131069 (2016).","journal-title":"Tumour Biol"},{"key":"BFsrep37576_CR36","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1158\/1055-9965.EPI-10-0994","volume":"20","author":"EM Kwon","year":"2011","unstructured":"Kwon, E. M. et al. Genetic polymorphisms in inflammation pathway genes and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 20, 923\u2013933 (2011).","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFsrep37576_CR37","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00432-011-1103-0","volume":"138","author":"LE Wang","year":"2012","unstructured":"Wang, L. E. et al. Roles of genetic variants in the PI3K and RAS\/RAF pathways in susceptibility to endometrial cancer and clinical outcomes. J Cancer Res Clin Oncol 138, 377\u2013385 (2012).","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFsrep37576_CR38","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ctrv.2008.09.006","volume":"35","author":"AS Strimpakos","year":"2009","unstructured":"Strimpakos, A. S., Karapanagiotou, E. M., Saif, M. W. & Syrigos, K. N. The role of mTOR in the management of solid tumors: an overview. Cancer Treat Rev 35, 148\u2013159 (2009).","journal-title":"Cancer Treat Rev"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep37576.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep37576","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep37576.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T02:20:12Z","timestamp":1672885212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep37576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,23]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,23]]}},"alternative-id":["BFsrep37576"],"URL":"https:\/\/doi.org\/10.1038\/srep37576","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,23]]},"assertion":[{"value":"7 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37576"}}